ADVERTISEMENT

Coronavirus | Mumbai-based Haffkine gets Centre’s nod to produce Covaxin

April 15, 2021 11:56 pm | Updated April 16, 2021 08:10 am IST - Mumbai

A vial of COVID-19 vaccine COVAXIN. File

Haffkine Biopharma Corporation, Mumbai, has received permission from the Union government to manufacture Covaxin, an anti-coronavirus vaccine of Bharat Biotech, on technology transfer basis.

Chief Minister Uddhav Thackeray thanked Prime Minister Narendra Modi for this late on Thursday evening.

The State government had sent the proposal to the Centre in the last week of February saying the infrastructure of Haffkine, which is known for vaccine production, could be used for corona vaccine production in the country. Mr. Thackeray had even raised the issue in his video-conference with Mr. Modi, last month.

ADVERTISEMENT

State Chief Secretary Sitaram Kunte received a letter from Renu Swarup, Secretary of Science and Technology Ministry, Government of India, granting permission, for one year, based on the recommendation of the technical committee of scientists. The letter said experienced and trained technicians should be appointed at the earliest to ensure production of the vaccine.

Mr. Thackeray has directed Mr. Kunte to appoint a senior official to monitor the project and ensure timely delivery of the vaccine.

This is a Premium article available exclusively to our subscribers. To read 250+ such premium articles every month
You have exhausted your free article limit.
Please support quality journalism.
You have exhausted your free article limit.
Please support quality journalism.
The Hindu operates by its editorial values to provide you quality journalism.
This is your last free article.

ADVERTISEMENT

ADVERTISEMENT